IRIS PubliCatt

Marino, Mariapaola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.919
EU - Europa 1.363
AS - Asia 351
AF - Africa 17
SA - Sud America 14
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.910
SE - Svezia 475
IT - Italia 216
DE - Germania 198
CN - Cina 183
IE - Irlanda 122
FR - Francia 96
SG - Singapore 81
UA - Ucraina 67
IN - India 38
GB - Regno Unito 37
RU - Federazione Russa 37
FI - Finlandia 29
BE - Belgio 21
PL - Polonia 17
CI - Costa d'Avorio 11
HK - Hong Kong 11
CH - Svizzera 10
BR - Brasile 8
IR - Iran 8
NL - Olanda 8
AU - Australia 7
CA - Canada 7
TR - Turchia 7
CZ - Repubblica Ceca 6
ES - Italia 6
JP - Giappone 5
KR - Corea 4
NO - Norvegia 4
BY - Bielorussia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
MX - Messico 2
NZ - Nuova Zelanda 2
RO - Romania 2
ZA - Sudafrica 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CY - Cipro 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
VN - Vietnam 1
Totale 3.675
Salva come PNG Salva come JPEG
Città #
Chandler 532
Ashburn 232
Dublin 122
San Mateo 89
New York 67
Marseille 52
Singapore 52
Cattolica 49
Wilmington 49
Rome 48
Princeton 46
Ann Arbor 45
Boston 42
Jacksonville 41
Milan 38
Bremen 35
Moscow 33
Redwood City 33
Chicago 27
Beijing 26
Dearborn 26
Woodbridge 26
Boardman 25
Nanjing 24
Houston 20
Brussels 17
Kraków 17
Helsinki 16
Falls Church 15
Norwalk 15
Seattle 14
Los Angeles 12
Abidjan 11
Fairfield 10
Washington 10
Edinburgh 9
Lawrence 9
Nanchang 9
Hebei 8
Hong Kong 8
Chengdu 7
Atlanta 6
Hangzhou 6
Izmir 6
Lancaster 6
Zurich 6
Brno 5
Changsha 5
Jiaxing 5
Mountain View 5
Sacramento 5
Shenyang 5
São Paulo 5
Augusta 4
Berlin 4
Bern 4
Falkenstein 4
Melbourne 4
Munich 4
Nürnberg 4
Oslo 4
Paris 4
Pune 4
San Francisco 4
San Jose 4
Tianjin 4
Toronto 4
University Park 4
Amsterdam 3
Baltimore 3
Busan 3
Busto Arsizio 3
Dallas 3
Esslingen am Neckar 3
Guangzhou 3
Kish 3
Kunming 3
Lachine 3
Lappeenranta 3
Leawood 3
London 3
Minsk 3
Muravera 3
Naples 3
Nuremberg 3
Philadelphia 3
Salt Lake City 3
Tokyo 3
Zhengzhou 3
Alatri 2
Auckland 2
Baotou 2
Borgonovo Val Tidone 2
Budapest 2
Changchun 2
Changzhou 2
Colombo 2
Ferentino 2
Fuzhou 2
Genzano di Roma 2
Totale 2.176
Salva come PNG Salva come JPEG
Nome #
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 147
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 145
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 128
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 113
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 113
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 103
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 98
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 96
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 89
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 85
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 78
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 77
Skeletal muscle cells: from local inflammatory response to active immunity 76
Immunological role of IgG subclasses 74
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 73
Immunological role of IgG subclasses 71
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 71
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 69
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 68
Myasthenia gravis with antibodies to MuSK: an update 66
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 64
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 63
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 63
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 63
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 62
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 62
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 61
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 61
The Laboratory Role in anti-TNF Biological Therapy Era 60
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 59
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 57
Cryoglobulins: putative effectors of adaptive immune response 56
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 55
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 55
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 54
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 54
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 53
IL-6, monocyte infiltration and parenchymal cells 52
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 52
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 52
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 49
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 49
Free light chains and autoimmunity 48
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 45
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 44
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 43
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 42
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 42
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 41
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 36
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 35
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 27
Immune-inflammatory response changes in patients with major depressive disorder 27
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 24
The dark side of current analytic methods for Bence Jones Proteinuria 24
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 23
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 22
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 22
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 21
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 20
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 17
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 16
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 15
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 14
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 12
Fluidi ed elettroliti. Equilibrio acido-base 12
Type 2 cytokines and scleroderma interstitial lung disease 10
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 9
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 8
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 8
Calprotectin: two sides of the same coin 6
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 5
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 5
Totale 3.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020219 54 8 9 4 7 11 47 6 5 10 46 12
2020/2021259 22 12 3 16 71 16 16 8 22 6 53 14
2021/2022600 24 15 13 63 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/202544 44 0 0 0 0 0 0 0 0 0 0 0
Totale 3.819